This brand name is authorized in Estonia, Croatia, Ireland, Lithuania, Poland
The drug OGLUO contains one active pharmaceutical ingredient (API):
1
Glucagon
UNII 1H87NVF4DB - GLUCAGON HYDROCHLORIDE
|
Glucagon is a hyperglycaemic agent that mobilises hepatic glycogen, which is released into the blood as glucose. Glucagon inhibits the tone and motility of the smooth muscle in the gastrointestinal tract. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
OGLUO Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
H04AA01 | Glucagon | H Systemic hormonal preparations, excl. Sex hormones and insulins → H04 Pancreatic hormones → H04A Glycogenolytic hormones → H04AA Glycogenolytic hormones |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1841813, 1841824, 1841835, 1841846, 1841857, 1841868, 1841879, 1841880 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1092063, 1092064, 1092065, 1092066, 1092067, 1092068, 1092069, 1092070 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100448499, 100448507, 100448520, 100448536 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.